Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?

Yohann Loriot, P. Mordant, E. Deutsch

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

3 Citations (Scopus)

Accès au document

@article{908705f0fec5419cbe8176a206b7b163,

title = "Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?",

author = "Yohann Loriot and P. Mordant and E. Deutsch",

year = "2009",

month = mar,

day = "11",

doi = "10.1093/annonc/mdn772",

language = "English",

volume = "20",

pages = "596--597",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "3",

}

TY - JOUR

T1 - Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer

T2 - bad drug, bad target, neither or both?

AU - Loriot, Yohann

AU - Mordant, P.

AU - Deutsch, E.

PY - 2009/3/11

Y1 - 2009/3/11

UR - http://www.scopus.com/inward/record.url?scp=61649093043&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdn772

DO - 10.1093/annonc/mdn772

M3 - Letter

C2 - 19164457

AN - SCOPUS:61649093043

SN - 0923-7534

VL - 20

SP - 596

EP - 597

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -